tirzepatide weight loss first month average per reduction over time in tirzepatide‐treated participants by early weight response: Post hoc analysis in SURMOUNT‐1 average weight loss week – Starting April 1 - May

Experimental data show a significant reduction in healing duration for various muscle lesions

The failure to warn is one of the strongest claims in the Ozempic lawsuit

But it doesnt affect other birth control methods

Upregulate Growth Factors: Studies suggest it can increase the expression of key growth factor receptors involved in tissue repair

Use: In combination with a reduced calorie diet and increased physical activity, for the treatment of noncirrhotic MASH with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) Usual Pediatric Dose for Weight Loss 12 YEARS AND OLDER: Wegovy Injection: Initial dose (weeks 1 through 4): 0.25 mg subcutaneously once a week Dose escalation: Weeks 5 through 8: 0.5 mg subcutaneously once a week Weeks 9 through 12: 1 mg subcutaneously once a week Weeks 13 through 16: 1.7 mg subcutaneously once a week Alternatively: 1.7 mg subcutaneously once a week Comments: The recommended maintenance dose is 2.4 mg

It represents a paradigm shift in metabolic therapeutics, addressing both hyperglycemia and excess adiposity with a single molecular intervention